The mainstay of treatment for<unk><unk>  disease is pharmacotherapy. Treatment of Helicobacter pylori with antimicrobial agents is indicated for patients with gastric or duodenal<unk> ation.  Pharmacologic therapies for<unk><unk>  disease due to H. pylori is either triple or quadruple pharmacologic agents that include a Proton pump inhibitors plus a combination of antimicrobial agents. After the first line therapy, patient is tested for persistent H.pylori infection. If the patient has persistent infection, treatment is planned according to previous antibiotics therapy. Salvage treatment is used for failure of first line therapy. The use of antimicrobial therapy is discouraged among asymptomatic carriers.
Peptic ulcer medical therapy
Dyspepsia medical therapy
Aphthous ulcer medical therapy
Stomatitis medical therapy
Peptic ulcer surgery
Gastroesophageal reflux disease medical therapy
Hemochromatosis medical therapy
Celiac disease medical therapy